OppenheimerFunds’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $581M | Sell |
1,153,526
-2
| -0% | -$1.19K | 0.72% | 27 |
|
|
2018
Q4 | $569M | Buy |
1,153,528
+353,377
| +44% | +$213M | 0.81% | 18 |
|
|
2018
Q3 | $732M | Buy |
800,151
+29,432
| +4% | +$25.1M | 0.85% | 15 |
|
|
2018
Q2 | $565M | Buy |
770,719
+56,351
| +8% | +$65M | 0.67% | 23 |
|
|
2018
Q1 | $1.14B | Sell |
714,368
-259,270
| -27% | -$334M | 1.42% | 5 |
|
|
2017
Q4 | $872M | Sell |
973,638
-677,844
| -41% | -$401M | 1.06% | 8 |
|
|
2017
Q3 | $595M | Sell |
1,651,482
-32,333
| -2% | -$10.1M | 0.73% | 19 |
|
|
2017
Q2 | $494M | Buy |
1,683,815
+83,094
| +5% | +$24M | 0.61% | 30 |
|
|
2017
Q1 | $564M | Sell |
1,600,721
-66,500
| -4% | -$14.9M | 0.68% | 18 |
|
|
2016
Q4 | $307M | Buy |
1,667,221
+247
| +0% | +$50.2K | 0.39% | 68 |
|
|
2016
Q3 | $430M | Sell |
1,666,974
-66,716
| -4% | -$17.2M | 0.54% | 33 |
|
|
2016
Q2 | $370M | Sell |
1,733,690
-161
| -0% | -$36K | 0.49% | 47 |
|
|
2016
Q1 | $358M | Buy |
1,733,851
+293
| +0% | +$56.3K | 0.47% | 51 |
|
|
2015
Q4 | $438M | Sell |
1,733,558
-26,442
| -2% | -$5.44M | 0.56% | 39 |
|
|
2015
Q3 | $289M | Buy |
1,760,000
+26,667
| +2% | +$4.72M | 0.39% | 66 |
|
|
2015
Q2 | $325M | Hold |
1,733,333
| – | – | 0.37% | 65 |
|
|
2015
Q1 | $286M | Buy |
1,733,333
+120,000
| +7% | +$24.7M | 0.32% | 88 |
|
|
2014
Q4 | $375M | Sell |
1,613,333
-13,334
| -0.8% | -$2.85M | 0.42% | 60 |
|
|
2014
Q3 | $295M | Hold |
1,626,667
| – | – | 0.32% | 80 |
|
|
2014
Q2 | $313M | Hold |
1,626,667
| – | – | 0.35% | 72 |
|
|
2014
Q1 | $296M | Buy |
1,626,667
+93,334
| +6% | +$18.5M | 0.35% | 74 |
|
|
2013
Q4 | $261M | Hold |
1,533,333
| – | – | 0.32% | 79 |
|
|
2013
Q3 | $240M | Buy |
1,533,333
+20,000
| +1% | +$3.7M | 0.32% | 86 |
|
|
2013
Q2 | $262M | Buy |
+1,513,333
| New | +$232M | 0.38% | 61 |
|
Other funds holding NKTR
